Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D.L. Bowtell, Frances R. Balkwill, Steffen Böhm et al.|Nature reviews. Cancer|2015Cited by 1.4k
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung CancerMichael J. Topper, Stephen B. Baylin, Reiner Strick et al.|Cell|2017Cited by 521
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Katherine B. Chiappinelli|Scientific Reports|2020Cited by 112
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancerStephanie Gomez, Katherine B. Chiappinelli|Journal for ImmunoTherapy of Cancer|2022Cited by 37
Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element LociTomas Kanholm, Katherine B. Chiappinelli|Cancer Research|2023Cited by 27